BMC Infectious Diseases

Papers
(The H4-Index of BMC Infectious Diseases is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients505
Serial interval and incubation period of COVID-19: a systematic review and meta-analysis263
SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis171
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial146
Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study135
Predictors of willingness to get a COVID-19 vaccine in the U.S127
Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis125
Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine124
Effects of undernutrition on mortality and morbidity among adults living with HIV in sub-Saharan Africa: a systematic review and meta-analysis124
Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial123
COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection118
The diagnostic value of metagenomic next⁃generation sequencing in infectious diseases115
Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI105
Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis99
Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak98
Hospital length of stay for COVID-19 patients: Data-driven methods for forward planning96
Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers in New Jersey, at the onset of the U.S. COVID-19 pandemic94
The microbiology of diabetic foot infections: a meta-analysis92
Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea86
The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing86
Modes of transmission of SARS-CoV-2 and evidence for preventive behavioral interventions86
Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy83
Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris80
Antibiotic resistance in Pakistan: a systematic review of past decade77
Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal f77
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial73
A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-273
Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-1970
Correlation between white blood cell count at admission and mortality in COVID-19 patients: a retrospective study68
‘Long COVID’: persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria67
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients65
Clinical outcomes in patients co-infected with COVID-19 and Staphylococcus aureus: a scoping review63
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials63
Coronavirus seasonality, respiratory infections and weather62
Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-1961
Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review59
COVID-19 viral load not associated with disease severity: findings from a retrospective cohort study58
Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus57
Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance56
Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation56
Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from urinary tract infections: a systematic review and meta-analysis54
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial53
Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors52
Carbon dioxide increases with face masks but remains below short-term NIOSH limits51
Predictors of COVID-19 vaccine hesitancy among Egyptian healthcare workers: a cross-sectional study50
High risk groups for severe COVID-19 in a whole of population cohort in Australia50
The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis50
Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis49
Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 201849
Low incidence of COVID-19 case severity and mortality in Africa; Could malaria co-infection provide the missing link?49
0.19666814804077